Drawing for GRAIL

USPTO serial 86984014

GRAIL

Reviewed by CopyMark Law Group

Reg. 5561536Status 704Registered
Filing date
Status date
Registration date
Sep 11, 2018
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with GRAIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donald A Thompson

Donald A Thompson THOMPSON & CO.595 Pacific Ave., 4th FloorSan Francisco, CA 94133United States

Goods and services

ClassDescriptionStatusFirst use
001[ Assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use ]SECTION 8 - CANCELLEDFeb 8, 2017
005[ Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and ] medical diagnostics or screening kits comprised of reagents for medical diagnostics or screening use [ ; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes ]ACTIVEFeb 8, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 8, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jun 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 21, 2025ES8RTEAS SECTION 8 RECEIVED—
Aug 29, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 11, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 18, 2022WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Feb 18, 2022WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Sep 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 11, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 7, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 6, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 25, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 25, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Jul 24, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 9, 2018IUAFUSE AMENDMENT FILED—
Jul 9, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Jul 9, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 9, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2018EX3GSOU EXTENSION 3 GRANTED—
May 7, 2018EXT3SOU EXTENSION 3 FILED—
May 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 1, 2017EX2GSOU EXTENSION 2 GRANTED—
Nov 1, 2017EXT2SOU EXTENSION 2 FILED—
Nov 1, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2017EX1GSOU EXTENSION 1 GRANTED—
May 15, 2017EXT1SOU EXTENSION 1 FILED—
May 15, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 13, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 22, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 27, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 27, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 19, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 16, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2016CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 13, 2016COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 8, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 5, 2016ALIEASSIGNED TO LIE—
Jun 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 20, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 6, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2016DOCKASSIGNED TO EXAMINER—
Apr 21, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 18, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance